|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
35,410,000 |
Market
Cap: |
13.80(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$202.16 - $413.31 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 463 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Medpace Holdings is a holding company. Through its subsidiaries, Co. is a clinical contract research organization focused on providing scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Co. provides a suite of services supporting the clinical development process from Phase I to Phase IV across a range of therapeutic areas. Co.'s services include medical department, clinical trial management, study start-up, patient recruitment and retention, clinical monitoring, risk-based monitoring, regulatory affairs, medical writing, biometrics and data sciences, pharmacovigilance, and quality assurance.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
2,000,000 |
Total Buy Value |
$0 |
$0 |
$0 |
$309,116,534 |
Total People Bought |
0 |
0 |
0 |
2 |
Total Buy Transactions |
0 |
0 |
0 |
34 |
Total Shares Sold |
1,680,302 |
2,142,702 |
3,658,182 |
3,746,608 |
Total Sell Value |
$677,990,238 |
$828,020,256 |
$1,211,498,112 |
$1,231,172,624 |
Total People Sold |
6 |
6 |
8 |
8 |
Total Sell Transactions |
44 |
64 |
93 |
100 |
End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Burwig Susan E |
Sr. Vice President, Operations |
|
2016-08-17 |
4 |
B |
$29.20 |
$525,600 |
D/D |
18,000 |
19,211 |
2.74 |
- |
|
Burwig Susan E |
Sr. Vice President, Operations |
|
2016-08-16 |
4 |
B |
$29.30 |
$35,482 |
D/D |
1,211 |
1,211 |
2.74 |
- |
|
Troendle August J. |
President & CEO |
|
2016-08-16 |
4 |
B |
$23.00 |
$19,999,995 |
D/D |
869,565 |
1,221,416 |
3.23 |
- |
|
Medpace Investors, Llc |
10% Owner |
|
2016-08-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,210,118 |
|
- |
|
Fifth Cinven Fund Co-Investment Partnership |
10% Owner |
|
2016-08-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
22,999,997 |
|
- |
|
Troendle August J. |
President & CEOOfficer |
|
2016-08-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
9,210,118 |
|
- |
|
Troendle August J. |
President & CEOOfficer |
|
2016-08-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
351,851 |
|
- |
|
Fifth Cinven Fund (no. 6) Limited Partnership |
10% Owner |
|
2016-08-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
22,999,997 |
|
- |
|
533 Records found
|
|
Page 22 of 22 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|